Trial Profile
Esomeprazole 20mg versus rabeprazole 10mg for the resolution of gastroesophageal reflux symptoms, Non-Inferiority randomized open-label cross over comparative study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 07 Sep 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 10 Sep 2013 New trial record